About SRS Life Sciences
SRS Life Sciences is a Healthcare company based in Singapore (Singapore) founded in 2001. It develops therapies and diagnostics to address diseases in emerging markets. It operates on a B2B and D2C model. The company has 87 employees. Its Indian entity Srs Pharmaceuticals Private Limited reported revenue of ₹88.26 Cr. SRS Life Sciences offers products and services including Therapies, Drug Delivery Systems, and Medical Diagnostics. Its focus areas include Life Sciences, Therapeutics, Disease Treatment and Medical Devices.
Company details
SRS Life Sciences focuses on identifying and solving pressing healthcare needs in emerging nations by innovating drug delivery systems, formulations, and medical diagnostics. They provide a portfolio of therapies for diseases like pneumonia and tuberculosis, emphasizing accessibility and impact through collaborations. Headquartered in Singapore, they aim to alleviate disease burdens globally.
- Headquarters Singapore, Singapore
- Employees 87
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website srslife.com
- Social LinkedIn X Facebook
- Legal Name Srs Pharmaceuticals Private Limited
- Date of Incorporation 27 Mar, 2001
- Jurisdiction Mumbai, Maharashtra, India
- Indian entity revenue₹88.26 Cr
FY 2025 · -10% YoY
- Indian entity net loss-₹12.52 Cr
FY 2025 · -14% margin
- Indian entity EBITDA-₹3.28 Cr
FY 2025 · -4% margin
- Employee Count87
Associated legal entities of SRS Life Sciences
SRS Life Sciences operates through Srs Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Srs Pharmaceuticals Private Limited CIN U24239MH2001PTC131384 | Active | 27 Mar 2001 | Mumbai, Maharashtra | ₹88.3 Cr | 87 | 4 | View details |
Products & Services of SRS Life Sciences
SRS Life Sciences offers a comprehensive portfolio of products and services, including Therapies, Drug Delivery Systems, and Medical Diagnostics.
Treatments targeting diseases like pneumonia and tuberculosis.
Innovative formulations for effective drug administration.
Tools for identifying and monitoring health conditions.
Board of directors of Srs Pharmaceuticals Private Limited (SRS Life Sciences)
Srs Pharmaceuticals Private Limited is the primary company behind SRS Life Sciences. The board of Srs Pharmaceuticals Private Limited currently have 3 directors; the longest-serving is Suchet Shyamsunder Rastogi, appointed in 2001. 7 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Suchet Shyamsunder Rastogi DIN 01161072 | Director | 27 Mar 2001 | 25 yrs 6 mo | Srs Pharmaceuticals Private Limited |
| Pooja Ketan Deshpande DIN 10649214 | Director | 10 Jun 2024 | 2 yrs 4 mo | Srs Pharmaceuticals Private Limited |
| Anuradha Ganesh Naik DIN 10975073 | Additional Director | 30 Apr 2025 | 1 yr 5 mo | Srs Pharmaceuticals Private Limited |
People of SRS Life Sciences
9 people are tracked at SRS Life Sciences (5 in leadership, 4 in team); the tracked headcount is 87.
| Name | Role | Group |
|---|---|---|
Sanjay Adlakha | General Manager-africa | Leadership |
Chandrashekar Kadam | Chief Diplomat | Leadership |
| Group Chief Executive Officer | Leadership | |
Shailesh Yadav | Chief Diplomat | Leadership |
Rajan Dubey | Chief Technical Strategist | Leadership |
Sangeeta Gamre | Strategic Executor | Team |
Shrikant Shinde | Logistics Enabler | Team |
Dinesh Dantkale | Innovation Sherpa | Team |
Archana Maskar | Research Chef | Team |
Complete people profiles for SRS Life Sciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of SRS Life Sciences
Figures of Srs Pharmaceuticals Private Limited, the primary company behind SRS Life Sciences, for FY 2025. Revenue was ₹88.26 Cr (-10% year on year). Net loss was -₹12.52 Cr (-14% margin). EBITDA was -₹3.28 Cr (-4% margin). Revenue has grown at a compounded annual rate of -31% over three years and +4% over five years.
- ₹88.26 CrRevenue · FY 2025 · -10% YoY
- -₹12.52 CrNet loss · -14% margin
- -₹3.28 CrEBITDA · -4% margin
- ₹5.00 CrPaid-up capital
- 87Employees (provident fund records)
- -31%Revenue CAGR, 3 years
- +4%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Srs Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for SRS Life Sciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Srs Life Sciences
Complete news archive for SRS Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SRS Life Sciences
SRS Life Sciences was founded in 2001.
SRS Life Sciences is headquartered in Singapore, Singapore.
SRS Life Sciences has 87 employees.
The primary company behind SRS Life Sciences, Srs Pharmaceuticals Private Limited, reported revenue of ₹88.26 Cr for FY 2025, down 10% year on year.
SRS Life Sciences focuses on identifying and solving pressing healthcare needs in emerging nations by innovating drug delivery systems, formulations, and medical diagnostics. They provide a portfolio of therapies for diseases like pneumonia and tuberculosis, emphasizing accessibility and impact through collaborations. Headquartered in Singapore, they aim to alleviate disease burdens globally.
SRS Life Sciences offers Therapies, Drug Delivery Systems, and Medical Diagnostics.
SRS Life Sciences operates through Srs Pharmaceuticals Private Limited.
The legal entities of SRS Life Sciences currently have 4 directors, including Pooja Ketan Deshpande, Suchet Shyamsunder Rastogi, Komal Dilip Jain and others.